4.8 Article

Microbiome alteration via fecal microbiota transplantation is effective for refractory immune checkpoint inhibitor-induced colitis

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Oncology

Interleukin-6 blockade abrogates immunotherapy toxicity and promotes tumor immunity

Yared Hailemichael et al.

Summary: Immune checkpoint blockade therapy can cause immune-related adverse events. IL-6 expression is higher in colitis and Th17 cells are more prevalent in immune-related enterocolitis. Anti-CTLA-4 induces stronger Th17 memory in colitis than anti-PD-1. In mouse models, IL-6 blockade enhances tumor control and increases CD4(+)/CD8(+) effector T cell density, while reducing Th17, macrophages, and myeloid cells. Combined IL-6 blockade and ICB enhances tumor rejection and mitigates EAE symptoms. IL-6 blockade with ICB can decouple autoimmunity from antitumor immunity.

CANCER CELL (2022)

Article Biochemistry & Molecular Biology

Nivolumab plus ipilimumab with or without live bacterial supplementation in metastatic renal cell carcinoma: a randomized phase 1 trial

Nazli Dizman et al.

Summary: Adding a live bacterial product to an immunotherapy combination can enhance the clinical outcome in patients with metastatic renal cell carcinoma, showing longer progression-free survival and higher response rate.

NATURE MEDICINE (2022)

Article Immunology

Intestinal toxicity to CTLA-4 blockade driven by IL-6 and myeloid infiltration

Yifan Zhou et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2022)

Article Gastroenterology & Hepatology

Bacterial Mucosa-associated Microbiome in Inflamed and Proximal Noninflamed Ileum of Patients With Crohn's Disease

Maya Olaisen et al.

Summary: The study found that the microbiome in the inflamed and proximal noninflamed ileal mucosa is similar in patients with Crohn's disease (CD). Additionally, Crohn's disease patients had a significantly different microbiome compared to healthy controls.

INFLAMMATORY BOWEL DISEASES (2021)

Editorial Material Gastroenterology & Hepatology

Efficacy and Outcome of Tofacitinib in Immune checkpoint Inhibitor Colitis

Shrinivas Bishu et al.

GASTROENTEROLOGY (2021)

Article Multidisciplinary Sciences

Fecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients

Erez N. Baruch et al.

Summary: This study conducted a phase 1 clinical trial and found that FMT treatment in patients with anti-PD-1-refractory metastatic melanoma, along with reinduction of anti-PD-1 immunotherapy, resulted in clinical responses in some patients. This suggests that modulating the gut microbiota could be a promising approach in cancer treatment.

SCIENCE (2021)

Article Microbiology

Bifidobacterium bifidum strains synergize with immune checkpoint inhibitors to reduce tumour burden in mice

Se-Hoon Lee et al.

Summary: Specific strains of Bifidobacterium bifidum can reduce tumor burden synergistically with PD-1 blockade or oxaliplatin treatment by eliciting an antitumor host immune response, indicating their potential therapeutic use.

NATURE MICROBIOLOGY (2021)

Letter Medicine, General & Internal

Ustekinumab for Refractory Colitis Associated with Immune Checkpoint Inhibitors

Anusha S. Thomas et al.

Summary: Two patients developed severe refractory autoimmune colitis after cancer treatment with immune checkpoint inhibitors, but responded well to a course of subcutaneously administered ustekinumab, an antibody that blocks interleukin-12/23 signaling.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Multidisciplinary Sciences

Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response

Christine N. Spencer et al.

Summary: The study suggests that dietary fiber intake is associated with significantly improved progression-free survival in melanoma patients receiving ICB treatment, especially without the use of probiotics. Preclinical studies demonstrate that a low-fiber diet or probiotics can impair the treatment response to anti-PD-1 therapy, leading to a lower frequency of interferon-gamma-positive cytotoxic T cells in the tumor microenvironment.

SCIENCE (2021)

Article Multidisciplinary Sciences

Fecal microbiota transplant overcomes resistance to anti-PD-1 therapy in melanoma patients

Diwakar Davar et al.

Summary: The study demonstrated that fecal microbiota transplantation combined with anti-PD-1 therapy can overcome resistance to anti-PD-1 in a subset of PD-1 refractory melanoma patients, leading to clinical benefits. This approach induced changes in the gut microbiome and reprogrammed the tumor microenvironment, ultimately enhancing the efficacy of anti-PD-1 treatment.

SCIENCE (2021)

Article Multidisciplinary Sciences

Immuno-profiling and cellular spatial analysis using five immune oncology multiplex immunofluorescence panels for paraffin tumor tissue

Edwin Roger Parra et al.

Summary: The study optimized five mIF panels for immuno-profiling tumor tissues, identifying correlations between B7-H4 and OX40 expression with malignant cells and revealing an immunosuppressive microenvironment.

SCIENTIFIC REPORTS (2021)

Article Biology

Integrating taxonomic, functional, and strain-level profiling of diverse microbial communities with bioBakery 3

Francesco Beghini et al.

Summary: Culture-independent analyses of microbial communities have advanced significantly in the past decade, particularly due to the emergence of Shotgun Metagenomics. bioBakery 3, a newly developed toolset, enhances the accuracy and scope of taxonomic, functional, and phylogenetic profiling in microbial community studies by providing an expanding set of reference sequences.
Review Endocrinology & Metabolism

Unhealthy Lifestyle and Gut Dysbiosis: A Better Understanding of the Effects of Poor Diet and Nicotine on the Intestinal Microbiome

Jason E. Martinez et al.

Summary: The study of the intestinal microbiome is gaining attention for its bidirectional communication with the host impacting immunity and metabolism. Factors like poor dietary choices and nicotine consumption contribute to metabolic diseases like non-alcoholic fatty liver disease through gut dysbiosis.

FRONTIERS IN ENDOCRINOLOGY (2021)

Review Biochemistry & Molecular Biology

Best Practices for Technical Reproducibility Assessment of Multiplex Immunofluorescence

Caddie Laberiano-Fernandez et al.

Summary: Multiplex immunofluorescence (mIF) with tyramide signal amplification is a valuable tool for cancer research, but requires careful attention to antibody selection, staining optimization, panel design, and data analysis strategies to ensure high reproducibility and address challenges.

FRONTIERS IN MOLECULAR BIOSCIENCES (2021)

Article Oncology

Association of Chronic Immune-Mediated Diarrhea and Colitis With Favorable Cancer Response

Fangwen Zou et al.

Summary: Chronic IMDC is associated with proton pump inhibitor use, longer duration of symptoms, hospitalization, specific histologic features, delayed introduction of immunosuppressive therapy, better cancer response to immune checkpoint inhibitors, and improved overall survival. Higher doses of selective immunosuppressive therapy are also associated with better overall survival.

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2021)

Review Oncology

Gut Microbiota in Cancer Immune Response and Immunotherapy

Cheng-Bei Zhou et al.

Summary: This article summarizes the complex interplay among the gut microbiome, cancer immune response, and immunotherapy, pointing out that modulation of the host microbiota can provide new strategies for cancer treatment.

TRENDS IN CANCER (2021)

Article Gastroenterology & Hepatology

Bacterial Mucosa-associated Microbiome in Inflamed and Proximal Noninflamed Ileum of Patients With Crohn's Disease

Maya Olaisen et al.

Summary: The microbiome in the ileum of patients with Crohn's disease is similar in inflamed and proximal noninflamed areas, with no significant differences in diversity or bacterial taxa. This suggests that CD-specific microbiota alterations are consistent across different regions of the ileum.

INFLAMMATORY BOWEL DISEASES (2021)

Review Immunology

The microbiota and immune-mediated diseases: Opportunities for therapeutic intervention

Gillian Fitzgibbon et al.

EUROPEAN JOURNAL OF IMMUNOLOGY (2020)

Article Multidisciplinary Sciences

Comparing bioinformatic pipelines for microbial 16S rRNA amplicon sequencing

Andrei Prodan et al.

PLOS ONE (2020)

Article Gastroenterology & Hepatology

Microbial imbalance in inflammatory bowel disease patients at different taxonomic levels

Mohammad Tauqeer Alam et al.

GUT PATHOGENS (2020)

Review Cell Biology

Interaction between microbiota and immunity in health and disease

Danping Zheng et al.

CELL RESEARCH (2020)

Review Gastroenterology & Hepatology

Secondary causes of inflammatory bowel diseases

Yezaz A. Ghouri et al.

WORLD JOURNAL OF GASTROENTEROLOGY (2020)

Article Multidisciplinary Sciences

Bifidobacterium alters the gut microbiota and modulates the functional metabolism of T regulatory cells in the context of immune checkpoint blockade

Shan Sun et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)

Article Oncology

Tocilizumab for the management of immune mediated adverse events secondary to PD-1 blockade

Chipman R. G. Stroud et al.

JOURNAL OF ONCOLOGY PHARMACY PRACTICE (2019)

Article Multidisciplinary Sciences

Bifidobacterium can mitigate intestinal immunopathology in the context of CTLA-4 blockade

Feng Wang et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)

Article Multidisciplinary Sciences

Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients

V. Gopalakrishnan et al.

SCIENCE (2018)

Review Immunology

Adaptive immune education by gut microbiota antigens

Qing Zhao et al.

IMMUNOLOGY (2018)

Review Oncology

Gut microbiome modulates efficacy of immune checkpoint inhibitors

Ming Yi et al.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2018)

Article Biochemistry & Molecular Biology

Fecal microbiota transplantation for refractory immune checkpoint inhibitor-associated colitis

Yinghong Wang et al.

NATURE MEDICINE (2018)

Review Oncology

Linking Gut Microbiota to Colorectal Cancer

Hans Raskov et al.

JOURNAL OF CANCER (2017)

Review Immunology

Host-microbial Cross-talk in Inflammatory Bowel Disease

Hiroko Nagao-Kitamoto et al.

IMMUNE NETWORK (2017)

Review Oncology

Immune Checkpoint Inhibitor Therapy: What Line of Therapy and How to Choose?

Chethan Ramamurthy et al.

CURRENT TREATMENT OPTIONS IN ONCOLOGY (2017)

Review Oncology

Microbiota: a key orchestrator of cancer therapy

Soumen Roy et al.

NATURE REVIEWS CANCER (2017)

Review Microbiology

CD Taxonomy, Physiology, and Natural Products of Actinobacteria

Essaid Ait Barka et al.

MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS (2016)

Article Gastroenterology & Hepatology

Cancer Immunotherapy with Anti-CTLA-4 Monoclonal Antibodies Induces an Inflammatory Bowel Disease

L. Marthey et al.

JOURNAL OF CROHNS & COLITIS (2016)

Article Multidisciplinary Sciences

Intestinal microbiome analyses identify melanoma patients at risk for checkpoint-blockade-induced colitis

Krista Dubin et al.

NATURE COMMUNICATIONS (2016)

Review Microbiology

Bifidobacteria and Their Role as Members of the Human Gut Microbiota

Amy O'Callaghan et al.

FRONTIERS IN MICROBIOLOGY (2016)

Article Multidisciplinary Sciences

VSEARCH: a versatile open source tool for metagenomics

Torbjorn Rognes et al.

Review Gastroenterology & Hepatology

Systematic review: colitis associated with anti-CTLA-4 therapy

A. Gupta et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2015)

Article Biotechnology & Applied Microbiology

Use of 16S rRNA Gene-Targeted Group-Specific Primers for Real-Time PCR Analysis of Predominant Bacteria in Mouse Feces

Yun-Wen Yang et al.

APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2015)

Article Multidisciplinary Sciences

Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota

Marie Vetizou et al.

SCIENCE (2015)

Article Genetics & Heredity

Complex host genetics influence the microbiome in inflammatory bowel disease

Dan Knights et al.

GENOME MEDICINE (2014)

Article Biotechnology & Applied Microbiology

Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2

Michael I. Love et al.

GENOME BIOLOGY (2014)

Review Microbiology

The gut microbiota - masters of host development and physiology

Felix Sommer et al.

NATURE REVIEWS MICROBIOLOGY (2013)

Article Oncology

Immune Checkpoint Inhibitors: Making Immunotherapy a Reality for the Treatment of Lung Cancer

Julie R. Brahmer et al.

CANCER IMMUNOLOGY RESEARCH (2013)

Article Biotechnology & Applied Microbiology

Introducing mothur: Open-Source, Platform-Independent, Community-Supported Software for Describing and Comparing Microbial Communities

Patrick D. Schloss et al.

APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2009)

Article Biochemistry & Molecular Biology

SILVA:: a comprehensive online resource for quality checked and aligned ribosomal RNA sequence data compatible with ARB

Elmar Pruesse et al.

NUCLEIC ACIDS RESEARCH (2007)

Article Biotechnology & Applied Microbiology

Quantitative and qualitative beta diversity measures lead to different insights into factors that structure microbial communities

Catherine A. Lozupone et al.

APPLIED AND ENVIRONMENTAL MICROBIOLOGY (2007)